Development, diagnostic performance, and interobserver agreement of a 18F-flurpiridaz PET automated perfusion quantitation system
- PMID: 32895856
- PMCID: PMC7936994
- DOI: 10.1007/s12350-020-02335-6
Development, diagnostic performance, and interobserver agreement of a 18F-flurpiridaz PET automated perfusion quantitation system
Abstract
Background: Computerized methodologies standardize the myocardial perfusion imaging (MPI) interpretation process.
Methods: To develop an automated relative perfusion quantitation approach for 18F-flurpiridaz, PET MPI studies from all phase III trial participants of 18F-flurpiridaz were divided into 3 groups. Count distributions were obtained in N = 40 normal patients undergoing pharmacological or exercise stress. Then, N = 90 additional studies were selected in a derivation group. Following receiver operating characteristic curve analysis, various standard deviations below the mean normal were used as cutoffs for significant CAD, and interobserver variability determined. Finally, diagnostic performance was compared between blinded visual readers and blinded derivations of automated relative quantitation in the remaining N = 548 validation patients.
Results: Both approaches yielded comparable accuracies for the detection of global CAD, reaching 71% and 72% by visual reads, and 72% and 68% by automated relative quantitation, when using CAD ≥ 70% or ≥ 50% stenosis for significance, respectively. Similar results were observed when analyzing individual coronary territories. In both pharmacological and exercise stress, automated relative quantitation demonstrated significantly more interobserver agreement than visual reads.
Conclusions: Our automated method of 18F-flurpiridaz relative perfusion analysis provides a quantitative, objective, and highly reproducible assessment of PET MPI in normal and CAD subjects undergoing either pharmacological or exercise stress.
Keywords: Flurpiridaz; PET MPI; automated relative quantitation; diagnostic performance; interobserver variability.
© 2020. American Society of Nuclear Cardiology.
Figures









Comment in
-
Automation in Nuclear Cardiology: Time for Flurpiridaz to Join the Club.J Nucl Cardiol. 2022 Apr;29(2):709-711. doi: 10.1007/s12350-020-02421-9. Epub 2020 Nov 17. J Nucl Cardiol. 2022. PMID: 33205327 No abstract available.
References
-
- Parker MW, Iskandar A, Limone B, Perugini A, Kim H, Jones C, et al. Diagnostic accuracy of cardiac positron emission tomography versus single photon emission computed tomography for coronary artery disease: a bivariate meta-analysis. Circ Cardiovasc Imaging 2012;5:700–7. - PubMed
-
- Mc Ardle BA, Dowsley TF, deKemp RA, Wells GA, Beanlands RS. Does Rubidium-82 PET Have Superior Accuracy to SPECT Perfusion Imaging for the Diagnosis of Obstructive Coronary Disease? A Systematic Review and Meta-Analysis. J Am Coll Cardiol 2012;60:1828–1837. - PubMed
-
- Bateman TM, Heller GV, McGhie AI, Friedman JD, Case JA, Bryngelson JR, et al. Diagnostic accuracy of rest/stress ECG-gated Rb-82 myocardial perfusion PET: comparison with ECG-gated Tc-99m sestamibi SPECT. J Nucl Cardiol 2006;13:24–33. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous